Sleep Disorder Market

  • Published on 2025-11-09
  • Report Code: 1148
  • 170-350 pages
Sleep Disorder Market

Sleep Disorder Market: Segmented: By Disorder (Insomnia, Hypersomnia, Sleep Apnea, Sleep Breathing Disorders, Circadian Rhythm Disorders, Parasomnia, Sleep Movement Disorders), By Device (Sleep Apnea Devices, Sleep Laboratories, Mattresses & Pillows), By Treatment (Psychiatric Treatment, Behavioral Treatment, Cognitive Behavioral Therapy, Medication Therapy) And Region - Global Analysis of Market Size, Share & Trends For 2019-2021 And Forecasts To 2031

Table Of Content

Contents          

  1. Executive Summary
  2. Global Sleep Disorder Market
    1. Product Overview
    2. Market Definition
    3. Segmentation
    4. Assumptions and Acronyms
  3. Research Methodology
    1. Research Objectives
    2. Primary Research
    3. Secondary Research
    4. Forecast Model
    5. Market Size Estimation
  4. Average Pricing Analysis
  5. Macro-Economic Indicators
  6. Market Dynamics
    1. Growth Drivers
    2. Restraints
    3. Opportunity
    4. Trends
  7. Correlation & Regression Analysis
    1. Correlation Matrix
    2. Regression Matrix
  8. Recent Development, Policies & Regulatory Landscape
  9. Risk Analysis
    1. Demand Risk Analysis
    2. Supply Risk Analysis
  10. Global Sleep Disorder Market Analysis
    1. Porters Five Forces
      1. Threat of New Entrants
      2. Bargaining Power of Suppliers
      3. Threat of Substitutes
      4. Rivalry
    2. PEST Analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
  11. Global Sleep Disorder Market
    1. Market Size & forecast, 2020A-2030F
      1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12. Global Sleep Disorder Market: Market Segmentation
    1. By Regions
      1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    2. By Disorder: Market Share (2020-2030F)
      1. Insomnia, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Hypersomnia,  By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Sleep Apnea, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Sleep Breathing Disorders, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. Circadian Rhythm Disorders, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      6. Parasomnia, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      7. Sleep Movement Disorders, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    3. By Devices: Market Share (2020-2030F)
      1. Sleep Apnea Devices, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Sleep Laboratories, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Mattresses & Pillows, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    4. Treatment: Market Share (2020-2030F)
      1. Psychiatric Treatment, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Cognitive Behavioral Therapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Behavioral Treatment, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Medication Therapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  13. Company Profile    
    1. Cadwell Laboratories Inc
      1. Company Overview
      2. Company Total Revenue (Financials)
      3. Market Potential
      4. Global Presence
      5. Key Performance Indicators
      6. SWOT Analysis
      7. Product Launch
    2. GlaxoSmithKline plc,
    3. Becton Dickson and Company,
    4. Cardinal Health,
    5. Takeda Pharmaceutical Company Limited,
    6. Koninklijke Philips N.V
    7. Teva Pharmaceutical Industries Ltd.
    8. Astellas Pharma Inc,
    9. Cadwell Laboratories Inc.,
    10. Compumedics Limited
    11. Other Prominent Players

Consultant Recommendation

The above-given segmentation and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

To request a free sample copy of this report, please complete the form below.

Select License Type

$ 4950

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

Read all reports

Our Clients

We have been working with some Fortune 500+ clients